02.03.2015 • News

Bachem acquires American Peptide Company

Bachem announced today the forthcoming acquisition of American Peptide Company (APC), based in California. The Japanese seller ILS, a wholly-owned subsidiary of Otsuka Chemical, and the buyer, Bachem Americas have signed a contract to transfer all shares of APC. Both parties have agreed not to disclose the terms of the deal.

Company

Logo:

Bachem

Hauptstr. 144
4416 Bubendorf
Switzerland

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.